Amylyx director granted 24,372 stock options
Amylyx Pharmaceuticals director Bernhardt G. Zeiher received a grant of 24,372 stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amylyx Pharmaceuticals director Bernhardt G. Zeiher received a grant of 24,372 stock options. These options give the right to buy 24,372 shares of Amylyx common stock at an exercise price of $14.31 per share and expire on June 3, 2036.
According to the terms, the options vest in full on the earlier of June 4, 2027 or the date of the next annual meeting, as long as the director remains in continuous service with the company through that vesting date. After this grant, the director holds 24,372 derivative securities directly.
Insider Trade Summary
Grant/Award: 24,372 shares
Grant/Award
1 txn
Insider
Zeiher Bernhardt G
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 24,372 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 24,372 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Key Figures
Options granted: 24,372 options
Exercise price: $14.31 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Options granted
24,372 options
Stock Option (right to buy) granted on June 4, 2026
Exercise price
$14.31 per share
Conversion or exercise price of granted options
Expiration date
June 3, 2036
Option expiration for director grant
Post-grant derivative holdings
24,372 options
Total shares underlying options following transaction
Vesting date trigger
June 4, 2027 or next annual meeting
Full vesting contingent on continuous service to vesting date
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 14.3100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to this option shall vest in full upon the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
derivative securities financial
"derivativeTransactionCount: 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Amylyx (AMLX) director Bernhardt G. Zeiher receive in this Form 4?
Bernhardt G. Zeiher received a grant of 24,372 stock options to acquire Amylyx common shares at a set price. This is a compensation-related award, not an open-market purchase or sale, and represents his reported derivative holdings after the transaction.
What is the exercise price and expiration for the new Amylyx (AMLX) stock options?
The granted stock options have an exercise price of $14.31 per share and expire on June 3, 2036. This means the director can buy Amylyx common shares at $14.31 any time before that expiration date, once the options are vested.
When do Bernhardt G. Zeiher’s Amylyx (AMLX) options vest?
The options vest in full on the earlier of June 4, 2027 or the date of the next annual meeting. Vesting requires the director’s continuous service with Amylyx through that date, aligning the award with ongoing board participation.
Does this Amylyx (AMLX) Form 4 show any stock being bought or sold on the market?
No open-market buys or sells are reported; it only shows a grant of 24,372 stock options. The transaction is coded as an award acquisition, a common form of equity-based director compensation rather than a discretionary market trade.
How many Amylyx (AMLX) derivative securities does the director hold after this grant?
Following the option grant, the director is reported as holding 24,372 derivative securities directly. Each option corresponds to one underlying share of Amylyx common stock, giving him rights to purchase up to 24,372 shares upon exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates